Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Jan 24, 2020

SELL
$77.9 - $98.54 $886,657 - $1.12 Million
-11,382 Closed
0 $0
Q3 2019

Oct 16, 2019

BUY
$74.21 - $82.92 $71,686 - $80,100
966 Added 9.27%
11,382 $897,000
Q2 2019

Jul 26, 2019

BUY
$68.24 - $75.87 $59,505 - $66,158
872 Added 9.14%
10,416 $786,000
Q1 2019

Apr 23, 2019

BUY
$65.72 - $71.66 $46,661 - $50,878
710 Added 8.04%
9,544 $661,000
Q4 2018

Jan 29, 2019

BUY
$61.31 - $73.73 $35,498 - $42,689
579 Added 7.01%
8,834 $576,000
Q3 2018

Nov 06, 2018

BUY
$71.66 - $82.93 $101,828 - $117,843
1,421 Added 20.79%
8,255 $601,000
Q2 2018

Jul 25, 2018

BUY
$58.93 - $74.24 $113,086 - $142,466
1,919 Added 39.04%
6,834 $486,000
Q1 2018

May 03, 2018

BUY
$54.51 - $65.8 $267,916 - $323,407
4,915 New
4,915 $293,000

Others Institutions Holding CSLLY

About CSL LTD


  • Ticker CSLLY
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 964,432,000
  • Market Cap $84.7B
  • Description
  • CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plas...
More about CSLLY
Track This Portfolio

Track Advisor Partners LLC Portfolio

Follow Advisor Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisor Partners LLC with notifications on news.